Gastrointestinal Stent Market By Product (Duodenal, Pancreatic, Colonic, Biliary), Type [Metal (SEMS, Balloon-expandable, Nitinol, Stainless Steel), Plastic, Biodegradable], Application (Colorectal & Stomach Cancer), End User - Global Forecast to 2031

icon1
USD 0.82 BN
MARKET SIZE, 2031
icon2
CAGR 5.7%
(2026-2031)
icon3
500
REPORT PAGES
icon4
480
MARKET TABLES

GASTROINTESTINAL STENT MARKET SIZE, SHARE & GROWTH SNAPSHOT

gastrointestinal-gi-stent-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global gastrointestinal stent market is projected to grow from USD 0.62 billion in 2026 to USD 0.82 billion by 2031, at a CAGR of 5.7% during the forecast period. The market was valued at USD 0.59 billion in 2025. In addition to an increasing number of geriatric patients looking for palliative care and an increase in the use of minimally invasive procedures by healthcare providers, the growth of the gastrointestinal stent market can be attributed to a rising incidence rate of gastrointestinal diseases, such as colorectal and esophageal cancers, and biliary obstruction. Furthermore, stent technologies are constantly improving, leading to a rise in the use of self-expanding metal stents (SEMS) and better clinical results, which in turn support the market development. Besides, the promising reimbursement policies in developed countries and the growing healthcare facilities in developing countries are encouraging patients to opt for gastrointestinal stenting procedures.

KEY TAKEAWAYS

  • By Region
    The Asia Pacific gastrointestinal stent market is estimated to register the highest CAGR of 6.4% during the forecast period.
  • By Product Type
    By product, the biliary stents segment accounted for the largest share of 44.3% in 2025.
  • By Type
    By type, the self-expandable metals segment is expected to dominate the market with 70.1% share in 2025.
  • By Application
    By application, the gastrointestinal cancers segment is projected to grow at the fastest rate from 2026 to 2031.
  • By End User
    By end user, the hospital & clinics segment dominated the market, with a share of 84.4% in 2025.
  • Competitive Landscape - Key Players
    Boston Scientific Corporation, Cook Medical, Medtronic plc, Olympus Corporation, and BD were identified as leading players in the gastrointestinal stent market, driven by their strong global presence, extensive distribution networks, and comprehensive portfolios of advanced GI stenting and endoscopic solutions.
  • Competitive Landscape - Startups
    Leufen Medical GmbH, Allium Medical Solutions Ltd., Medorah Meditek Pvt. Ltd., Advin Health Care, among others, represent emerging and regional participants in the market, offering cost-effective gastrointestinal stents and focusing on niche applications, regional expansion, and competitive pricing strategies.

The gastrointestinal stent market is growing because more people have GI disorders like colorectal cancers and esophageal strictures, as well as biliary obstruction disorders. Another driving force for the burgeoning GI stent market is the popularity of minimally invasive outpatient surgeries and support for outpatient palliative care. New advancements in stent technologies, such as SEMS and biodegradable stents, along with improvements in the methods used to endoscopically place stents and increased availability of healthcare resources, will contribute to continued growth in the number of GI stents sold and the total amount of revenue from their sale.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The role of consumers' business in the GI stent market is influenced by the increase in the incidence of gastrointestinal diseases, enhanced focus on minimally invasive surgeries and improvements in stent and endoscopic technologies. Apart from hospitals, other prominent end users such as ambulatory surgery centers and specialty endoscopy clinics depend on manufacturers for the delivery of cutting edge and effective solutions for various conditions including biliary obstruction, esophageal strictures and colorectal cancers. With a strong focus on improving clinical outcomes, reducing procedure-related complications, and enhancing patient recovery times, there is a growing preference for advanced technology led solutions like biodegradable and drug-eluting stents. In fact, the need for cost-effective solutions, procedure efficiency and short hospital stays are the factors that are increasingly guiding the decision-making process in purchasing products in the gastrointestinal stents market.

gastrointestinal-gi-stent-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing incidence of gastrointestinal cancers and obstructive conditions, including colorectal, esophageal, and biliary disorders
  • Increasing adoption of minimally invasive and endoscopic procedures
RESTRAINTS
Impact
Level
  • High cost of advanced stents and endoscopic procedures
  • Limited access to advanced endoscopic infrastructure in developing regions
OPPORTUNITIES
Impact
Level
  • Technological advancements (biodegradable stents, drug-eluting stents, LAMS)
  • Increasing demand for palliative care and non-surgical treatment options
CHALLENGES
Impact
Level
  • Stringent regulatory approvals and clinical validation requirements
  • Lack of skilled endoscopists in low-resource settings

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing Incidence of Gastrointestinal Cancers and Obstructive Conditions

The increasing incidence of gastrointestinal diseases such as colorectal cancer, esophageal strictures, and biliary obstructions is a major factor in the rising demand for gastrointestinal stents. Most of these diseases result in the narrowing or blockage of the lumen, thereby necessitating rapid treatment to re-establish normal functioning. The worldwide rise in cancer and chronic GI diseases, together with the increasing rate of diagnosis, has led healthcare professionals to resort more and more to stenting techniques. These methods are considered effective and less invasive. This constant increase in the incidence of various diseases is the reason for the ever-growing requirement for gastrointestinal stents in both developed and developing countries.

Restraint: High Cost of Advanced Stents and Endoscopic Procedures

Advanced gastrointestinal stents, such as self-expanding metal stents (SEMS), drug-eluting stents, and lumen-apposing metal stents (LAMS), involve high manufacturing and material costs. Moreover, the equipment needed for endoscopy, as well as the presence of highly skilled professionals, are prerequisites for the placement procedure, making it more expensive. Such factors limit the affordability of the product mainly in developing countries, where the healthcare budget and the reimbursement coverage are very limited. Therefore, in regions such as developing countries, where healthcare budget constraints are high, the high cost of advanced gastrointestinal stents acts as a challenge to their growth in the market.

Opportunity: Technological Advancements in Gastrointestinal Stents

The ongoing improvements in stent design and materials have yielded considerable expansion prospects in the gastrointestinal stent market. Advances such as biodegradable stents, drug-eluting stents, and lumen-apposing metal stents (LAMS) are helping to improve patient outcomes by reducing complications such as restenosis and stent migration. Besides, these innovations also bring about an increase in the range of use cases and a higher number of physicians willing to carry out stenting procedures, which is the main reason for the growth of the market.

Challenge: Stringent Regulatory Approvals and Clinical Validation Requirements

Gastrointestinal stents face very strict regulatory approvals to ensure their safety and effectiveness, especially in developed markets like the US and Europe. Among other requirements, producers must conduct large-scale clinical studies and meet high-quality standards, which can increase the time and cost required to bring the product to market. Additionally, differing regulations across various localities may create challenges in entering the international market. As a result, product shipments can be delayed, and the pace of introducing new ideas can be limited. Therefore, compliance with these rules becomes a major obstacle for the gastrointestinal stent market.

GASTROINTESTINAL STENT MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Provides a comprehensive portfolio of gastrointestinal stents, including AXIOS lumen-apposing metal stents, WallFlex biliary, esophageal, colonic, and duodenal stents, and Agile esophageal stents. These are used for drainage of pancreatic fluid collections, treatment of malignant strictures, and maintenance of luminal patency in GI obstructions. Enables minimally invasive management of complex GI conditions; supports effective drainage and obstruction relief; reduces need for surgical interventions; improves patient recovery and clinical outcomes.
Offers a wide range of GI stents, including Evolution esophageal and biliary stents and Zilver metal stents used for managing malignant and benign strictures across the gastrointestinal tract. Strong focus on endoscopic delivery systems. Provides reliable and flexible stenting solutions; enhances physician control during placement; supports palliative care and improves patient quality of life.
Provides GI stenting solutions through its endoscopy portfolio, including self-expanding metal stents for esophageal and biliary applications, used in minimally invasive treatment of GI obstructions and cancers. Improves procedural efficiency and treatment accessibility; supports large-scale hospital adoption; enhances patient outcomes through minimally invasive approaches.
Offers endoscopic stent solutions integrated with advanced imaging and endoscopy systems, supporting placement of GI stents for esophageal, biliary, and pancreatic conditions. Enhances precision and visualization during procedures; improves procedural safety and physician efficiency; strengthens end-to-end GI treatment ecosystem.
Provides GI and biliary stenting solutions through its interventional portfolio , focusing on minimally invasive management of obstructions and strictures. Supports effective obstruction management; leverages strong global distribution; improves treatment access and clinical outcomes.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The gastrointestinal stent industry involves a diverse range of stakeholders that take part in various activities such as developing, distributing, and using stenting solutions for treating gastrointestinal disorders. Among the most important players are medical device manufacturers, suppliers of raw materials, providers of components, and research institutions that help product innovation and clinical progress. Besides, regulatory authorities and government bodies have an indispensable role in ensuring that the products are safe and effective as well as in enforcing compliance through rigorous approval procedures and quality standards. Distributors and channel partners provide market reach and product presence in healthcare establishments. On the demand side, end users consisting of hospitals, ambulatory surgical centers, and specialty clinics that have embraced minimally invasive procedures for the treatment of gastrointestinal obstructions and other related diseases form the main driving force. The ecosystem is also affected by the frequency of the disease, technology development in the design of stents, and regulatory and reimbursement systems that are constantly changing.

gastrointestinal-gi-stent-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

gastrointestinal-gi-stent-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Gastrointestinal Stent Market, By Product

In 2025, biliary stents constitute the majority share in the market for gastrointestinal stents, making up nearly 44% of the entire market share. The main reasons behind this top position are the high incidence of biliary diseases and cancers, as well as the strong requirement for stenting procedures to remove blockages and allow bile flow. On the other hand, the usage of colonic and duodenal stents is limited to a small number of cases that are gradually increasing. Besides, the rising rate of pancreatic and esophageal diseases is boosting the demand for different product segments.

Gastrointestinal Stent Market, By Type

In 2025, self-expandable metal stents took the lead in the gastrointestinal stent market by making up 70% of the market share. The reason is their better flexibility, longer life, and capability to conform to complicated anatomical structures. These types of stents have been the top choice in minimally invasive surgeries for both cancerous and non-cancerous strictures. On the other hand, plastic stents are less expensive but are usually reserved for short-term use because they have a higher probability of getting clogged and are less durable.

Gastrointestinal Stent Market, By Application

Biliary diseases are a major segment within the gastrointestinal stent market, holding about 47% of the overall demand in 2025. This is largely because of the prevalence of biliary obstructions, gallstones, and associated cancers that require intervention. Besides, gastrointestinal cancers such as colorectal, stomach, pancreatic, and esophageal cancers also heavily influence the demand for the market since these cases often have to resort to palliative stenting methods. On the other hand, inflammatory bowel diseases and other benign conditions form quite smaller fractions but are very likely to grow in the future.

Gastrointestinal Stent Market, By End User

Hospitals dominate the gastrointestinal stent market, contributing around 84% of the market share globally in 2025. Since they work as the primary centers of advanced endoscopic procedures and complex gastrointestinal interventions, this also leads to them being the primary customers for these products. Their leading position is also due to the availability of specialized infrastructure, skilled gastroenterologists, and large patient inflow for cancer and obstruction-related treatments.

REGION

Asia Pacific to be fastest-growing region during forecast period

The gastrointestinal stents market is projected to grow the fastest in the Asia Pacific region. The main factors fueling this growth include the rising rates of gastrointestinal cancers and diseases, increased healthcare spending, and improved access to advanced medical technologies. Countries like China, India, and Japan are experiencing a significant rise in demand for minimally invasive procedures due to an aging population and greater awareness of early diagnosis and treatment. Additionally, the rapid expansion of new healthcare facilities, the increasing number of endoscopic procedures, and the adoption of new advanced stents are also driving growth within the region. Furthermore, various government healthcare reform initiatives aimed at improving access to quality care and a large patient base are further supporting the adoption of these devices in the region.

gastrointestinal-gi-stent-market Region

GASTROINTESTINAL STENT MARKET: COMPANY EVALUATION MATRIX

In the gastrointestinal stent market, Boston Scientific Corporation (Star) is the market leader, offering a comprehensive and diverse range of advanced GI stents. The company has a wide reach worldwide, supported by continuous innovation. Micro-Tech (Nanjing) Co., Ltd. (Emerging Leader) is rapidly expanding globally and offers cost-competitive products. The company's increasing number of regulatory approvals in the main markets is another factor that supports Micro-Tech's growth.

gastrointestinal-gi-stent-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 0.59 Billion
Market Size in 2026 (Value) USD 0.62 Billion
Market Size in 2031 (Value) USD 0.82 Billion
CAGR CAGR of 5.7% from 2026-2031
Years Considered 2024-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Million/Billion), Volume (Thousand Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Product:
    • Biliary Stent
    • Colonic Stent
    • Duodenal Stent
    • Pancreatic Stent
    • Esophageal Stent
  • By Type:
    • Metal Stent (Nitinol Stent
    • Stainless Steel Stent
    • Other Metal Stents
  • By Coverage:
    • Fully Covered Stent
    • Partially Covered Stent
    • Uncovered Stent
  • By Mechanism:
    • Self-Expanding Metal Stents (SEMS)
    • Balloon-Expandable Metal Stents (BEMS))
    • Plastic Stent
    • Biodegradable Stent (Polymer-Based Biodegradable Stent
    • Magnesium-Based Biodegradable Stent
    • Other Biodegradable Stents)
  • By Application:
    • Biliary Diseases
    • Gastrointestinal Cancer (Colorectal Cancer
    • Stomach Cancer
    • Pancreatic Cancer
    • Esophageal Cancer)
    • Irritable Bowel Syndrome
    • Benign Strictures & Leaks
    • Other Applications
  • By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Specialty Endoscopy Centers/GI Clinics
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: GASTROINTESTINAL STENT MARKET REPORT CONTENT GUIDE

gastrointestinal-gi-stent-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis Comparative analysis of key gastrointestinal stent product categories, including biliary, esophageal, colonic, and duodenal stents. Highlighted technology trends such as self-expanding metal stents (SEMS), biodegradable stents, and lumen-apposing metal stents (LAMS), along with advancements in endoscopic delivery systems and design innovations across major manufacturers. Enabled identification of high-demand application areas (cancer-related obstructions, strictures, palliative care), technology adoption trends, pricing dynamics, and product positioning strategies to support portfolio expansion and competitive benchmarking.
Company Information Profiled key players including Boston Scientific, Cook Medical, Medtronic, Olympus, BD, Micro-Tech (Nanjing), and M.I.Tech. Provided insights on GI stent product portfolios, technological capabilities, geographic presence, and strategic initiatives such as partnerships, expansions, and regulatory approvals. Delivered clarity on partnership and acquisition opportunities, competitive positioning, and investment hotspots influencing growth in the gastrointestinal stent market.
Geographic Analysis Provided detailed analysis of key regions, including North America and the Rest of Europe, for gastrointestinal stent demand. Assessed country-level factors such as prevalence of GI cancers, healthcare infrastructure, endoscopy adoption rates, reimbursement scenarios, and regulatory landscape. Supported regional expansion strategies by identifying high-growth markets, procedure-driven demand, localization opportunities, and distributor partnerships to accelerate market penetration.

RECENT DEVELOPMENTS

  • October 2025 : Boston Scientific Corporation announced that it has received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix™ Biliary Plastic Stents for the treatment of biliary strictures, including biliary stone disease, benign biliary strictures, and suspected and confirmed malignancies in the biliary system.
  • January 2025 : Micro-Tech celebrated the groundbreaking of its Thailand Manufacturing Center with a formal ceremony held in the Laem Chabang Industrial Estate, Bang Lamung District, Chonburi Province. The event marks a significant milestone in the company’s global expansion and its commitment to serving international markets with high-quality medical devices.
  • February 2023 : Olympus Corporation (Olympus), agreed to acquire Taewoong Medical Co., Ltd, (Taewoong Medical), a Korea-based manufacturer of medical devices such as gastrointestinal (GI) metallic stents to strengthen its GI EndoTherapy product portfolio capabilities, and in turn, contributing to improving patient outcome through comprehensive solutions.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
35
2
EXECUTIVE SUMMARY
 
 
 
 
 
41
3
PREMIUM INSIGHTS
 
 
 
 
 
47
4
MARKET OVERVIEW
Technological advancements and emerging market adoption drive growth in minimally invasive GI stenting.
 
 
 
 
 
51
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
RISING BURDEN OF GI CANCERS AND PANCREATICOBILIARY DISEASES
 
 
 
 
 
 
4.2.1.2
GROWING PREFERENCE FOR MINIMALLY INVASIVE ENDOSCOPIC PALLIATION
 
 
 
 
 
 
4.2.1.3
TECHNOLOGICAL ADVANCEMENTS IN GI STENTS
 
 
 
 
 
 
4.2.1.4
EXPANDING USE OF SEMS OVER PLASTIC STENTS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH DEVICE AND PROCEDURE COSTS
 
 
 
 
 
 
4.2.2.2
RISK OF STENT MIGRATION, PERFORATION, BLEEDING, AND RE-OBSTRUCTION
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
RISING ADOPTION IN EMERGING MARKETS
 
 
 
 
 
 
4.2.3.2
EXPANSION OF EUS-GUIDED STENTING PROCEDURES
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
NEED FOR HIGH OPERATOR EXPERTISE
 
 
 
 
 
 
4.2.4.2
REGULATORY AND POST-MARKET SAFETY SCRUTINY
 
 
 
 
4.3
UNMET NEEDS & WHITE SPACES
 
 
 
 
 
 
 
4.3.1
UNMET NEEDS IN GASTROINTESTINAL STENTS MARKET
 
 
 
 
 
 
4.3.2
WHITE SPACE OPPORTUNITIES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
 
4.4.1
INTERCONNECTED MARKETS
 
 
 
 
 
 
4.4.2
CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
 
 
4.5.1
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
5
INDUSTRY TRENDS
Discover competitive dynamics and pricing shifts shaping the global medical device landscape.
 
 
 
 
 
63
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.4
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC INDICATORS
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS & FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL HEALTHCARE INDUSTRY
 
 
 
 
 
 
5.2.4
TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS, BY KEY PLAYER, 2023–2025
 
 
 
 
 
 
 
5.5.1.1
AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS, BY KEY PLAYER, 2023−2025
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS, BY REGION, 2023–2025
 
 
 
 
 
 
 
5.5.2.1
AVERAGE SELLING PRICE TREND OF NITINOL STENTS, BY REGION, 2023−2025
 
 
 
 
 
 
5.5.2.2
AVERAGE SELLING PRICE TREND OF STAINLESS-STEEL STENTS, BY REGION, 2023−2025
 
 
 
 
 
 
5.5.2.3
AVERAGE SELLING PRICE TREND OF PLASTIC STENTS, BY REGION, 2023−2025
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
TRADE DATA FOR HS CODE 9018
 
 
 
 
 
 
 
5.6.1.1
IMPORT DATA FOR HS CODE 9018
 
 
 
 
 
 
5.6.1.2
EXPORT DATA FOR HS CODE 9018
 
 
 
 
 
5.6.2
TRADE DATA FOR HS CODE 9021
 
 
 
 
 
 
 
5.6.2.1
IMPORT DATA FOR HS CODE 9021
 
 
 
 
 
 
5.6.2.2
EXPORT DATA FOR HS CODE 9021
 
 
 
 
5.7
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
5.9
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.10
SUCCESS STORIES & REAL-WORLD APPLICATIONS
 
 
 
 
 
 
 
5.10.1
COLONIC STENTS FOR MALIGNANT COLORECTAL OBSTRUCTION
 
 
 
 
 
 
5.10.2
DUODENAL STENTS FOR GASTRODUODENAL OUTLET OBSTRUCTION
 
 
 
 
 
 
5.10.3
LARGE-CELL STENTS FOR MULTIPLE STENTING IN MALIGNANT HILAR BILIARY OBSTRUCTION
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFFS ON GASTROINTESTINAL STENTS MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.11.5.1
HOSPITALS & CLINICS
 
 
 
 
 
 
5.11.5.2
SPECIALTY ENDOSCOPY CENTERS/GI CLINICS
 
 
 
 
 
 
5.11.5.3
AMBULATORY SURGICAL CENTERS
 
 
 
6
SUSTAINABILITY & REGULATORY LANDSCAPE
Navigate complex regulations to leverage eco-friendly stent materials and sustainability standards globally.
 
 
 
 
 
88
 
6.1
REGIONAL REGULATIONS & COMPLIANCE
 
 
 
 
 
 
 
6.1.1
REGULATORY ANALYSIS
 
 
 
 
 
 
6.1.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
6.1.3
INDUSTRY STANDARDS
 
 
 
 
 
6.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
 
6.2.1
RECYCLED & ECO-FRIENDLY MATERIALS FOR GASTROINTESTINAL STENTS
 
 
 
 
 
 
6.2.2
SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
 
 
 
 
 
 
6.2.3
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
7
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Uncover stakeholder influence and unmet needs driving buyer behavior in gastrointestinal stent markets.
 
 
 
 
 
94
 
7.1
KEY STAKEHOLDERS & BUYING CRITERIA
 
 
 
 
 
 
 
 
7.1.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
7.1.2
BUYING CRITERIA
 
 
 
 
 
7.2
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
 
 
7.2.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
7.2.2
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
7.2.3
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
7.2.4
MARKET PROFITABILITY
 
 
 
 
8
STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
AI and 3D printing revolutionize personalized, biodegradable gastrointestinal stents for advanced, minimally invasive care.
 
 
 
 
 
99
 
8.1
TECHNOLOGY ANALYSIS
 
 
 
 
 
 
 
8.1.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
 
8.1.1.1
BIODEGRADABLE GASTROINTESTINAL STENTS
 
 
 
 
 
 
8.1.1.2
3D-PRINTED PERSONALIZED STENTS
 
 
 
 
 
8.1.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
8.1.2.1
ADVANCED ENDOSCOPIC IMAGING & AI-ASSISTED ENDOSCOPY
 
 
 
 
 
 
8.1.2.2
MINIMALLY INVASIVE SURGICAL DEVICES
 
 
 
 
 
8.1.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
8.1.3.1
SURFACE MODIFICATION TECHNOLOGIES
 
 
 
 
 
 
8.1.3.2
NITINOL ALLOY TECHNOLOGY
 
 
 
 
8.2
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
 
8.2.1
NEAR TERM (2025–2027)
 
 
 
 
 
 
8.2.2
MID TERM (2028–2030)
 
 
 
 
 
 
8.2.3
LONG TERM (2030+)
 
 
 
 
 
8.3
PATENT ANALYSIS
 
 
 
 
 
 
 
 
8.3.1
PATENT PUBLICATION TRENDS FOR GASTROINTESTINAL STENTS
 
 
 
 
 
 
8.3.2
JURISDICTION & TOP APPLICANT ANALYSIS
 
 
 
 
 
8.4
FUTURE APPLICATIONS
 
 
 
 
 
 
 
8.4.1
AI-ASSISTED ENDOSCOPY & STENT PLACEMENT
 
 
 
 
 
 
8.4.2
NEXT-GENERATION BIODEGRADABLE GI STENTS
 
 
 
 
 
 
8.4.3
PERSONALIZED & 3D-PRINTED GI STENTS
 
 
 
 
 
 
8.4.4
DRUG-ELUTING & SMART GI STENTS
 
 
 
 
 
 
8.4.5
ROBOTIC-ASSISTED & IMAGE-GUIDED GI INTERVENTIONS
 
 
 
 
 
8.5
IMPACT OF AI/GENERATIVE AI ON GASTROINTESTINAL STENTS MARKET
 
 
 
 
 
 
 
 
8.5.1
INTRODUCTION
 
 
 
 
 
 
8.5.2
MARKET POTENTIAL IN GASTROINTESTINAL STENTS ECOSYSTEM
 
 
 
 
 
 
8.5.3
AI USE CASES
 
 
 
 
 
 
8.5.4
KEY COMPANIES IMPLEMENTING AI IN GASTROINTESTINAL STENTS MARKET
 
 
 
 
9
GASTROINTESTINAL STENTS MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 12 Data Tables
 
 
 
 
 
111
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
BILIARY STENTS
 
 
 
 
 
 
 
9.2.1
RISING BURDEN OF HEPATOBILIARY AND PANCREATIC DISORDERS TO BOOST DEMAND
 
 
 
 
 
9.3
ESOPHAGEAL STENTS
 
 
 
 
 
 
 
9.3.1
INCREASING ESOPHAGEAL CANCER INCIDENCE TO DRIVE MARKET
 
 
 
 
 
9.4
COLONIC STENTS
 
 
 
 
 
 
 
9.4.1
GROWING PREFERENCE FOR MINIMALLY INVASIVE MANAGEMENT OF COLORECTAL OBSTRUCTIONS TO DRIVE MARKET
 
 
 
 
 
9.5
DUODENAL STENTS
 
 
 
 
 
 
 
9.5.1
EXPANDING USE OF ENDOSCOPIC PALLIATION TO FUEL MARKET GROWTH
 
 
 
 
 
9.6
PANCREATIC STENTS
 
 
 
 
 
 
 
9.6.1
RISING VOLUME OF ERCP PROCEDURES AND PANCREATIC DISEASE MANAGEMENT TO SUPPORT GROWTH
 
 
 
 
10
GASTROINTESTINAL STENTS MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Units | 26 Data Tables
 
 
 
 
 
124
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
METAL STENTS
 
 
 
 
 
 
 
10.2.1
METAL STENTS MARKET, BY TYPE
 
 
 
 
 
 
 
10.2.1.1
NITINOL STENTS
 
 
 
 
 
 
 
 
10.2.1.1.1
GROWING DEMAND FOR FLEXIBLE AND CONFORMABLE STENTS TO FUEL DEMAND
 
 
 
 
 
 
10.2.1.1.2
GLOBAL VOLUME ANALYSIS OF NITINOL STENTS, 2024–2031 (THOUSAND UNITS)
 
 
 
 
10.2.1.2
STAINLESS STEEL STENTS
 
 
 
 
 
 
 
 
10.2.1.2.1
INCREASING NEED FOR HIGH RADIAL FORCE SOLUTIONS TO SUPPORT ADOPTION
 
 
 
 
 
 
10.2.1.2.2
GLOBAL VOLUME ANALYSIS OF STAINLESS STEEL STENTS, 2024–2031 (THOUSAND UNITS)
 
 
 
 
10.2.1.3
OTHER METAL STENTS
 
 
 
 
 
10.2.2
METAL STENTS MARKET, BY MECHANISM
 
 
 
 
 
 
 
10.2.2.1
SELF-EXPANDING METAL STENTS (SEMS)
 
 
 
 
 
 
 
 
10.2.2.1.1
EXPANDING PREFERENCE FOR MINIMALLY INVASIVE CANCER PALLIATION TO DRIVE MARKET GROWTH
 
 
 
 
10.2.2.2
BALLOON-EXPANDABLE METAL STENTS (BEMS)
 
 
 
 
 
 
 
 
10.2.2.2.1
RISING DEMAND FOR PRECISE STENT DEPLOYMENT TO SUPPORT GROWTH
 
 
 
10.2.3
METAL STENTS MARKET, BY COVERAGE
 
 
 
 
 
 
 
10.2.3.1
UNCOVERED STENTS
 
 
 
 
 
 
 
 
10.2.3.1.1
GROWING USE IN MALIGNANT BILIARY OBSTRUCTION MANAGEMENT TO SUPPORT ADOPTION
 
 
 
 
10.2.3.2
FULLY COVERED STENTS
 
 
 
 
 
 
 
 
10.2.3.2.1
GREATER FOCUS ON PREVENTING TISSUE INGROWTH TO FUEL ADOPTION
 
 
 
 
10.2.3.3
PARTIALLY COVERED STENTS
 
 
 
 
 
 
 
 
10.2.3.3.1
INCREASING EMPHASIS ON BALANCING PATENCY AND MIGRATION CONTROL TO BOOST DEMAND
 
 
10.3
PLASTIC STENTS
 
 
 
 
 
 
 
10.3.1
INCREASING VOLUME OF TEMPORARY BILIARY AND PANCREATIC DRAINAGE PROCEDURES TO DRIVE DEMAND
 
 
 
 
 
 
10.3.2
GLOBAL VOLUME ANALYSIS OF PLASTIC STENTS, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
10.4
BIODEGRADABLE STENTS
 
 
 
 
 
 
 
10.4.1
GLOBAL VOLUME ANALYSIS OF BIODEGRADABLE STENTS, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
10.4.2
POLYMER-BASED BIODEGRADABLE STENTS
 
 
 
 
 
 
 
10.4.2.1
RISING UTILIZATION IN BENIGN STRICTURE TREATMENT TO SUPPORT GROWTH
 
 
 
 
 
10.4.3
MAGNESIUM-BASED BIODEGRADABLE STENTS
 
 
 
 
 
 
 
10.4.3.1
ADVANCEMENTS IN BIORESORBABLE METAL TECHNOLOGIES TO DRIVE MARKET GROWTH
 
 
 
 
 
10.4.4
OTHER BIODEGRADABLE STENTS
 
 
 
 
11
GASTROINTESTINAL STENTS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 10 Data Tables
 
 
 
 
 
154
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
GASTROINTESTINAL CANCER
 
 
 
 
 
 
 
11.2.1
PANCREATIC CANCER
 
 
 
 
 
 
 
11.2.1.1
INCREASING PANCREATIC CANCER BURDEN TO SUPPORT GROWTH
 
 
 
 
 
11.2.2
COLORECTAL CANCER
 
 
 
 
 
 
 
11.2.2.1
RISING COLORECTAL CANCER INCIDENCE TO DRIVE DEMAND
 
 
 
 
 
11.2.3
ESOPHAGEAL CANCER
 
 
 
 
 
 
 
11.2.3.1
GROWING NEED FOR DYSPHAGIA RELIEF TO ACCELERATE ESOPHAGEAL STENT ADOPTION
 
 
 
 
 
11.2.4
STOMACH CANCER
 
 
 
 
 
 
 
11.2.4.1
EXPANDING USE OF MINIMALLY INVASIVE PALLIATION TO BOOST MARKET GROWTH
 
 
 
 
11.3
BILIARY DISEASE
 
 
 
 
 
 
 
11.3.1
INCREASING PREVALENCE OF BILIARY OBSTRUCTIONS TO ACCELERATE MARKET GROWTH
 
 
 
 
 
11.4
BENIGN STRICTURES & LEAKS
 
 
 
 
 
 
 
11.4.1
GROWING ADOPTION OF ENDOSCOPIC MANAGEMENT OF BENIGN GI CONDITIONS TO FUEL MARKET GROWTH
 
 
 
 
 
11.5
OTHER APPLICATIONS
 
 
 
 
 
12
GASTROINTESTINAL STENTS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 4 Data Tables
 
 
 
 
 
170
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
HOSPITALS & CLINICS
 
 
 
 
 
 
 
12.2.1
RISING GASTROINTESTINAL CANCER BURDEN AND ADVANCED ENDOSCOPY CAPABILITIES TO DRIVE MARKET GROWTH
 
 
 
 
 
12.3
SPECIALTY ENDOSCOPY CENTERS/GI CLINICS
 
 
 
 
 
 
 
12.3.1
GROWING PREFERENCE FOR SPECIALIZED THERAPEUTIC ENDOSCOPY TO PROPEL MARKET
 
 
 
 
 
12.4
AMBULATORY SURGICAL CENTERS
 
 
 
 
 
 
 
12.4.1
SHIFT TOWARD OUTPATIENT MINIMALLY INVASIVE PROCEDURES TO FUEL GROWTH
 
 
 
 
13
GASTROINTESTINAL STENTS MARKET, BY REGION
Comprehensive coverage of 9 Regions with country-level deep-dive of 22 Countries | 331 Data Tables.
 
 
 
 
 
177
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
NORTH AMERICA
 
 
 
 
 
 
 
13.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
 
 
13.2.2
NORTH AMERICA: VOLUME ANALYSIS OF GASTROINTESTINAL STENTS, BY TYPE, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
13.2.3
US
 
 
 
 
 
 
 
13.2.3.1
HIGH GI DISEASE BURDEN AND PROCEDURAL VOLUME TO SUPPORT ADOPTION OF GI STENTS
 
 
 
 
 
13.2.4
CANADA
 
 
 
 
 
 
 
13.2.4.1
EXPANDING MINIMALLY INVASIVE GI INTERVENTIONS AND AGING DEMOGRAPHICS TO DRIVE MARKET
 
 
 
 
13.3
EUROPE
 
 
 
 
 
 
 
13.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
 
 
13.3.2
EUROPE: VOLUME ANALYSIS OF BIODEGRADABLE GASTROINTESTINAL STENTS, BY TYPE, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
13.3.3
GERMANY
 
 
 
 
 
 
 
13.3.3.1
GERMANY TO DOMINATE EUROPEAN MARKET
 
 
 
 
 
13.3.4
UK
 
 
 
 
 
 
 
13.3.4.1
EXPANDING NHS ADOPTION OF INNOVATIVE DEVICES TO SUPPORT MARKET GROWTH
 
 
 
 
 
13.3.5
FRANCE
 
 
 
 
 
 
 
13.3.5.1
STRONG FOCUS ON ADVANCED GI TREATMENTS AND REIMBURSEMENT COVERAGE TO BOOST ADOPTION
 
 
 
 
 
13.3.6
ITALY
 
 
 
 
 
 
 
13.3.6.1
GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET PENETRATION
 
 
 
 
 
13.3.7
SPAIN
 
 
 
 
 
 
 
13.3.7.1
EXPANDING ENDOSCOPY INFRASTRUCTURE TO FUEL GRADUAL MARKET GROWTH
 
 
 
 
 
13.3.8
NETHERLANDS
 
 
 
 
 
 
 
13.3.8.1
ADVANCED GASTROENTEROLOGY SERVICES AND INCREASING GI CANCER BURDEN TO BOOST ADOPTION
 
 
 
 
 
13.3.9
SWEDEN
 
 
 
 
 
 
 
13.3.9.1
HIGH HEALTHCARE EXPENDITURE TO FUEL MARKET GROWTH
 
 
 
 
 
13.3.10
POLAND
 
 
 
 
 
 
 
13.3.10.1
RISING CANCER INCIDENCE AND MODERNIZATION OF ENDOSCOPY SERVICES TO BOOST MARKET
 
 
 
 
 
13.3.11
REST OF EUROPE
 
 
 
 
 
13.4
ASIA PACIFIC
 
 
 
 
 
 
 
13.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
 
 
13.4.2
ASIA PACIFIC: VOLUME ANALYSIS OF GASTROINTESTINAL STENTS, BY TYPE, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
13.4.3
CHINA
 
 
 
 
 
 
 
13.4.3.1
CHINA TO DOMINATE APAC MARKET
 
 
 
 
 
13.4.4
JAPAN
 
 
 
 
 
 
 
13.4.4.1
AGING POPULATION AND ADVANCED ENDOSCOPY ECOSYSTEM TO FUEL MARKET GROWTH
 
 
 
 
 
13.4.5
INDIA
 
 
 
 
 
 
 
13.4.5.1
GROWING CANCER INCIDENCE AND IMPROVING HEALTHCARE ACCESS TO BOOST MARKET GROWTH
 
 
 
 
 
13.4.6
AUSTRALIA
 
 
 
 
 
 
 
13.4.6.1
MATURE HEALTHCARE SYSTEM AND FAVORABLE REGULATORY PATHWAYS TO ENABLE EARLY ADOPTION
 
 
 
 
 
13.4.7
SOUTH KOREA
 
 
 
 
 
 
 
13.4.7.1
HIGH SCREENING RATES AND ADVANCED CLINICAL CAPABILITIES TO BOOST MARKET GROWTH
 
 
 
 
 
13.4.8
THAILAND
 
 
 
 
 
 
 
13.4.8.1
INCREASING COLORECTAL AND HEPATOBILIARY CANCER CASES TO SUPPORT MARKET GROWTH
 
 
 
 
 
13.4.9
NEW ZEALAND
 
 
 
 
 
 
 
13.4.9.1
EXPANDING ELDERLY POPULATION AND STRONG CANCER CARE SERVICES TO BOOST DEMAND
 
 
 
 
 
13.4.10
REST OF ASIA PACIFIC
 
 
 
 
 
13.5
LATIN AMERICA
 
 
 
 
 
 
 
13.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
 
 
13.5.2
LATIN AMERICA: VOLUME ANALYSIS OF GASTROINTESTINAL STENTS, BY TYPE, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
13.5.3
BRAZIL
 
 
 
 
 
 
 
13.5.3.1
LARGE PATIENT POPULATION AND RISING COLORECTAL CANCER CASES TO PROPEL MARKET DEMAND
 
 
 
 
 
13.5.4
MEXICO
 
 
 
 
 
 
 
13.5.4.1
GROWING ENDOSCOPY CAPACITY AND DISEASE BURDEN TO SUPPORT STEADY MARKET GROWTH
 
 
 
 
 
13.5.5
ARGENTINA
 
 
 
 
 
 
 
13.5.5.1
INCREASING GASTROINTESTINAL CANCER INCIDENCE AND ADVANCED CLINICAL CAPABILITIES TO DRIVE GROWTH
 
 
 
 
 
13.5.6
REST OF LATIN AMERICA
 
 
 
 
 
13.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
 
13.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
 
 
13.6.2
MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF BIODEGRADABLE GASTROINTESTINAL STENTS, BY TYPE, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
13.6.3
GCC COUNTRIES
 
 
 
 
 
 
 
13.6.3.1
KINGDOM OF SAUDI ARABIA (KSA)
 
 
 
 
 
 
 
 
13.6.3.1.1
HEALTHCARE TRANSFORMATION INITIATIVES AND RISING CANCER PREVALENCE TO FUEL MARKET EXPANSION
 
 
 
 
13.6.3.2
UNITED ARAB EMIRATES (UAE)
 
 
 
 
 
 
 
 
13.6.3.2.1
MEDICAL TOURISM GROWTH AND ADVANCED HEALTHCARE INVESTMENTS TO STRENGTHEN ADOPTION
 
 
 
 
13.6.3.3
REST OF GCC COUNTRIES
 
 
 
 
 
13.6.4
REST OF MIDDLE EAST & AFRICA
 
 
 
 
14
COMPETITIVE LANDSCAPE
Discover market leaders and strategic shifts shaping the gastrointestinal stents sector's competitive edge.
 
 
 
 
 
319
 
14.1
INTRODUCTION
 
 
 
 
 
 
 
14.1.1
KEY STRATEGIES ADOPTED BY PLAYERS IN GASTROINTESTINAL STENTS MARKET
 
 
 
 
 
14.2
REVENUE ANALYSIS, 2023–2025
 
 
 
 
 
 
 
14.3
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
 
14.3.1
US GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
14.3.2
EUROPE GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
14.4
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
14.4.1
STARS
 
 
 
 
 
 
14.4.2
EMERGING LEADERS
 
 
 
 
 
 
14.4.3
PERVASIVE PLAYERS
 
 
 
 
 
 
14.4.4
PARTICIPANTS
 
 
 
 
 
 
14.4.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
14.4.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
14.4.5.2
REGION FOOTPRINT
 
 
 
 
 
 
14.4.5.3
PRODUCT FOOTPRINT
 
 
 
 
 
 
14.4.5.4
TYPE FOOTPRINT
 
 
 
 
14.5
COMPANY EVALUATION MATRIX: START-UPS/SMES, 2025
 
 
 
 
 
 
 
 
14.5.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
14.5.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
14.5.3
DYNAMIC COMPANIES
 
 
 
 
 
 
14.5.4
STARTING BLOCKS
 
 
 
 
 
 
14.5.5
COMPETITIVE BENCHMARKING: START-UPS/SMES, 2025
 
 
 
 
 
 
 
14.5.5.1
DETAILED LIST OF KEY START-UPS/SMES
 
 
 
 
 
 
14.5.5.2
COMPETITIVE BENCHMARKING OF START-UPS/SMES
 
 
 
 
14.6
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
 
14.6.1
FINANCIAL METRICS
 
 
 
 
 
 
14.6.2
COMPANY VALUATION
 
 
 
 
 
14.7
PRODUCT/BRAND COMPARISON
 
 
 
 
 
 
 
14.8
COMPETITIVE SCENARIO
 
 
 
 
 
15
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
340
 
15.1
KEY PLAYERS
 
 
 
 
 
 
 
15.1.1
BOSTON SCIENTIFIC CORPORATION
 
 
 
 
 
 
 
15.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
15.1.1.2
PRODUCTS OFFERED
 
 
 
 
 
 
15.1.1.3
MNM VIEW
 
 
 
 
 
 
 
 
15.1.1.3.1
RIGHT TO WIN
 
 
 
 
 
 
15.1.1.3.2
STRATEGIC CHOICES
 
 
 
 
 
 
15.1.1.3.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
15.1.2
COOK MEDICAL
 
 
 
 
 
 
15.1.3
OLYMPUS CORPORATION
 
 
 
 
 
 
15.1.4
M.I. TECH
 
 
 
 
 
 
15.1.5
MICRO-TECH (NANJING) CO., LTD.
 
 
 
 
 
 
15.1.6
MERIT MEDICAL SYSTEMS
 
 
 
 
 
 
15.1.7
MEDTRONIC
 
 
 
 
 
 
15.1.8
ELLA–CS, S.R.O.
 
 
 
 
 
 
15.1.9
STERIS
 
 
 
 
 
 
15.1.10
W. L. GORE & ASSOCIATES, INC.
 
 
 
 
 
 
15.1.11
BD
 
 
 
 
 
 
15.1.12
Q3 MEDICAL GROUP
 
 
 
 
 
 
15.1.13
MEDI-GLOBE GMBH
 
 
 
 
 
 
15.1.14
HOBBS MEDICAL INC.
 
 
 
 
 
 
15.1.15
BVM
 
 
 
 
 
15.2
OTHER PLAYERS
 
 
 
 
 
 
 
15.2.1
LEUFEN
 
 
 
 
 
 
15.2.2
ALLIUM
 
 
 
 
 
 
15.2.3
MEDORAH MEDITEK PVT. LTD.
 
 
 
 
 
 
15.2.4
MITRA INDUSTRIES
 
 
 
 
 
 
15.2.5
ENDOGI MEDICAL
 
 
 
 
 
 
15.2.6
ADVIN HEALTH CARE
 
 
 
 
 
 
15.2.7
HUNAN FUDE TECHNOLOGY CO., LTD.
 
 
 
 
 
 
15.2.8
HOSPI LINE EQUIPMENTS PVT. LTD.
 
 
 
 
 
 
15.2.9
CITEC
 
 
 
 
 
 
15.2.10
G-FLEX
 
 
 
 
16
RESEARCH METHODOLOGY
 
 
 
 
 
394
 
16.1
RESEARCH DATA
 
 
 
 
 
 
 
16.1.1
SECONDARY DATA
 
 
 
 
 
 
 
16.1.1.1
KEY SECONDARY SOURCES
 
 
 
 
 
16.1.2
PRIMARY DATA
 
 
 
 
 
 
16.1.3
PRIMARY SOURCES
 
 
 
 
 
 
 
16.1.3.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
16.1.3.2
KEY INDUSTRY INSIGHTS
 
 
 
 
 
 
16.1.3.3
BREAKDOWN OF PRIMARIES
 
 
 
 
16.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
16.2.1
APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
 
 
 
 
 
 
16.2.2
APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
 
 
 
 
 
 
16.2.3
APPROACH 3: TOP-DOWN APPROACH
 
 
 
 
 
 
16.2.4
APPROACH 4: BOTTOM-UP APPROACH
 
 
 
 
 
 
16.2.5
APPROACH 5: PRIMARY INTERVIEWS
 
 
 
 
 
 
16.2.6
APPROACH 6: DEMAND-SIDE APPROACH
 
 
 
 
 
 
16.2.7
APPROACH 7: VOLUME DATA ANALYSIS
 
 
 
 
 
16.3
DATA TRIANGULATION & MARKET BREAKDOWN
 
 
 
 
 
 
16.4
MARKET SHARE ASSESSMENT
 
 
 
 
 
 
16.5
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
 
16.5.1
STUDY ASSUMPTIONS
 
 
 
 
 
 
16.5.2
GROWTH RATE ASSUMPTIONS
 
 
 
 
 
16.6
RISK ASSESSMENT
 
 
 
 
 
 
 
16.6.1
RESEARCH LIMITATIONS
 
 
 
 
17
APPENDIX
 
 
 
 
 
413
 
17.1
DISCUSSION GUIDE
 
 
 
 
 
 
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
17.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
 
17.3.1
PRODUCT ANALYSIS
 
 
 
 
 
 
17.3.2
COMPANY INFORMATION
 
 
 
 
 
 
17.3.3
GEOGRAPHIC ANALYSIS
 
 
 
 
 
 
17.3.4
REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
 
 
 
 
 
 
17.3.5
COUNTRY-LEVEL VOLUME ANALYSIS, BY PRODUCT
 
 
 
 
 
 
17.3.6
MARKET SHARE ANALYSIS, BY PRODUCT (TOP 5 PLAYERS)
 
 
 
 
 
 
17.3.7
ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
 
 
 
 
 
17.4
RELATED REPORTS
 
 
 
 
 
 
17.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
 
 
 
 
 
 
TABLE 2
GASTROINTESTINAL STENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 3
GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION)
 
 
 
 
 
 
TABLE 4
AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS, BY KEY PLAYER, 2023–2025
 
 
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE TREND OF NITINOL STENTS, BY REGION, 2023−2025
 
 
 
 
 
 
TABLE 6
AVERAGE SELLING PRICE TREND OF STAINLESS-STEEL STENTS, BY REGION, 2023−2025
 
 
 
 
 
 
TABLE 7
AVERAGE SELLING PRICE TREND OF PLASTIC STENTS, BY REGION, 2023−2025
 
 
 
 
 
 
TABLE 8
IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 9
EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 10
IMPORT DATA FOR HS CODE 9021, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 11
EXPORT DATA FOR HS CODE 9021, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 12
GASTROINTESTINAL STENTS MARKET: MAJOR CONFERENCES & EVENTS IN 2026–2027
 
 
 
 
 
 
TABLE 13
CASE STUDY 1: COLONIC STENTS FOR MALIGNANT COLORECTAL OBSTRUCTION
 
 
 
 
 
 
TABLE 14
CASE STUDY 2: DUODENAL STENTS FOR GASTRODUODENAL OUTLET OBSTRUCTION
 
 
 
 
 
 
TABLE 15
CASE STUDY 3: LARGE-CELL STENTS FOR MULTIPLE STENTING IN MALIGNANT HILAR BILIARY OBSTRUCTION
 
 
 
 
 
 
TABLE 16
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 17
KEY PRODUCT-RELATED TARIFFS
 
 
 
 
 
 
TABLE 18
NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
 
 
 
 
 
 
TABLE 19
ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
 
 
 
 
 
 
TABLE 20
EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
 
 
 
 
 
 
TABLE 21
LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
 
 
 
 
 
 
TABLE 22
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 23
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 24
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 25
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 26
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROINTESTINAL STENTS
 
 
 
 
 
 
TABLE 27
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
 
 
TABLE 28
KEY DIFFERENCES BETWEEN BIODEGRADABLE & NON-BIODEGRADABLE METAL STENTS
 
 
 
 
 
 
TABLE 29
GASTROINTESTINAL STENTS MARKET: MAJOR PATENTS
 
 
 
 
 
 
TABLE 30
KEY COMPANIES IMPLEMENTING AI IN GASTROINTESTINAL STENTS MARKET
 
 
 
 
 
 
TABLE 31
GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 33
KEY PLAYERS OFFERING BILIARY STENTS
 
 
 
 
 
 
TABLE 34
BILIARY STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
KEY PLAYERS PROVIDING ESOPHAGEAL STENTS
 
 
 
 
 
 
TABLE 36
ESOPHAGEAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
KEY PLAYERS PROVIDING COLONIC STENTS
 
 
 
 
 
 
TABLE 38
COLONIC STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
KEY PLAYERS PROVIDING DUODENAL STENTS
 
 
 
 
 
 
TABLE 40
DUODENAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
KEY PLAYERS PROVIDING PANCREATIC STENTS
 
 
 
 
 
 
TABLE 42
PANCREATIC STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
KEY PLAYERS PROVIDING METAL STENTS
 
 
 
 
 
 
TABLE 45
METAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
NITINOL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
NITINOL STENTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
TABLE 49
STAINLESS STEEL STENTS MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 50
STAINLESS STEEL STENTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
TABLE 51
OTHER METAL STENTS MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 52
METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
SELF-EXPANDING METAL STENTS (SEMS) MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 54
BALLOON-EXPANDABLE METAL STENTS (BEMS) MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 55
METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
UNCOVERED STENTS MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 57
FULLY COVERED STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
PARTIALLY COVERED STENTS MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 59
KEY PLAYERS PROVIDING PLASTIC STENTS
 
 
 
 
 
 
TABLE 60
PLASTIC STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
PLASTIC STENTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
TABLE 62
KEY PLAYERS PROVIDING BIODEGRADABLE STENTS
 
 
 
 
 
 
TABLE 63
BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
BIODEGRADABLE STENTS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
TABLE 66
POLYMER-BASED BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
MAGNESIUM-BASED BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
OTHER BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
GASTROINTESTINAL STENTS MARKET FOR PANCREATIC CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
GASTROINTESTINAL STENTS MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
GASTROINTESTINAL STENTS MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
GASTROINTESTINAL STENTS MARKET FOR STOMACH CANCER, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
GASTROINTESTINAL STENTS MARKET FOR BILIARY DISEASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
GASTROINTESTINAL STENTS MARKET FOR BENIGN STRICTURES & LEAKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
GASTROINTESTINAL STENTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
GASTROINTESTINAL STENTS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
GASTROINTESTINAL STENTS MARKET FOR SPECIALTY ENDOSCOPY CENTERS/ GI CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
GASTROINTESTINAL STENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
GASTROINTESTINAL STENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
TABLE 85
NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
NORTH AMERICA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
NORTH AMERICA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
NORTH AMERICA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
NORTH AMERICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
NORTH AMERICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
US: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 96
US: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
US: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
US: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
US: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
US: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
US: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
US: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
US: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
US: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
CANADA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 106
CANADA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
CANADA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
CANADA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
CANADA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
CANADA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
CANADA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
CANADA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
CANADA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
CANADA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
EUROPE: BIODEGRADABLE GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
TABLE 116
EUROPE: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
EUROPE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
EUROPE: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
EUROPE: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
EUROPE: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
EUROPE: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
EUROPE: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
EUROPE: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
EUROPE: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
EUROPE: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
GERMANY: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 127
GERMANY: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
GERMANY: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
GERMANY: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
GERMANY: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
GERMANY: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
GERMANY: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
GERMANY: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
GERMANY: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
GERMANY: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
UK: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 137
UK: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
UK: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
UK: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
UK: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
UK: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
UK: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
UK: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
UK: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
UK: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
FRANCE: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 147
FRANCE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
FRANCE: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
FRANCE: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
FRANCE: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
FRANCE: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
FRANCE: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
FRANCE: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
FRANCE: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
FRANCE: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
ITALY: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 157
ITALY: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
ITALY: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
ITALY: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
ITALY: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
ITALY: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
ITALY: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
ITALY: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
ITALY: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
ITALY: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
SPAIN: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 167
SPAIN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
SPAIN: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
SPAIN: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
SPAIN: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
SPAIN: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
SPAIN: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
SPAIN: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
SPAIN: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
SPAIN: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
NETHERLANDS: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 177
NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
NETHERLANDS: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
NETHERLANDS: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
NETHERLANDS: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
NETHERLANDS: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
NETHERLANDS: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
SWEDEN: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 187
SWEDEN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
SWEDEN: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
SWEDEN: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
SWEDEN: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
SWEDEN: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
SWEDEN: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
SWEDEN: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
SWEDEN: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
SWEDEN: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
POLAND: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 197
POLAND: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
POLAND: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
POLAND: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
POLAND: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
POLAND: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
POLAND: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
POLAND: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
POLAND: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
POLAND: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
REST OF EUROPE: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
REST OF EUROPE: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
REST OF EUROPE: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
REST OF EUROPE: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
REST OF EUROPE: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
TABLE 216
ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
ASIA PACIFIC: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
ASIA PACIFIC: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
ASIA PACIFIC: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
ASIA PACIFIC: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
CHINA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 227
CHINA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
CHINA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
CHINA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
CHINA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
CHINA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
CHINA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
CHINA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
CHINA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
CHINA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
JAPAN: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 237
JAPAN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
JAPAN: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
JAPAN: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
JAPAN: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
JAPAN: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
JAPAN: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
JAPAN: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
JAPAN: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
JAPAN: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
INDIA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 247
INDIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
INDIA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
INDIA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
INDIA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
INDIA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
INDIA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
INDIA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
INDIA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
INDIA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
AUSTRALIA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 257
AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
AUSTRALIA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
AUSTRALIA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
AUSTRALIA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
AUSTRALIA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
AUSTRALIA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
SOUTH KOREA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 267
SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
SOUTH KOREA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
SOUTH KOREA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
SOUTH KOREA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
SOUTH KOREA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
SOUTH KOREA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
THAILAND: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 277
THAILAND: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
THAILAND: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
THAILAND: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
THAILAND: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
THAILAND: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
THAILAND: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
THAILAND: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
THAILAND: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
THAILAND: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
NEW ZEALAND: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 287
NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
NEW ZEALAND: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
NEW ZEALAND: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
NEW ZEALAND: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
NEW ZEALAND: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
NEW ZEALAND: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
REST OF ASIA PACIFIC: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
REST OF ASIA PACIFIC: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
REST OF ASIA PACIFIC: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
REST OF ASIA PACIFIC: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
LATIN AMERICA: BIODEGRADABLE GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
TABLE 306
LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
LATIN AMERICA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
LATIN AMERICA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
LATIN AMERICA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
LATIN AMERICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
LATIN AMERICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
BRAZIL: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 317
BRAZIL: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
BRAZIL: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
BRAZIL: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
BRAZIL: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
BRAZIL: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
BRAZIL: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
BRAZIL: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
BRAZIL: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
BRAZIL: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
MEXICO: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 327
MEXICO: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
MEXICO: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
MEXICO: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
MEXICO: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
MEXICO: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
MEXICO: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
MEXICO: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
MEXICO: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
MEXICO: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
ARGENTINA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 337
ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
ARGENTINA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
ARGENTINA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
ARGENTINA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
ARGENTINA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
ARGENTINA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
REST OF LATIN AMERICA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
REST OF LATIN AMERICA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
REST OF LATIN AMERICA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
REST OF LATIN AMERICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
MIDDLE EAST & AFRICA: BIODEGRADABLE GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS)
 
 
 
 
 
 
TABLE 356
MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
MIDDLE EAST & AFRICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
GCC COUNTRIES: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
GCC COUNTRIES: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
GCC COUNTRIES: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
GCC COUNTRIES: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 377
KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
KINGDOM OF SAUDI ARABIA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
KINGDOM OF SAUDI ARABIA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
KINGDOM OF SAUDI ARABIA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
KINGDOM OF SAUDI ARABIA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
UNITED ARAB EMIRATES: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 387
UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
UNITED ARAB EMIRATES: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
UNITED ARAB EMIRATES: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
UNITED ARAB EMIRATES: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
UNITED ARAB EMIRATES: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
UNITED ARAB EMIRATES: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
REST OF GCC COUNTRIES: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
REST OF GCC COUNTRIES: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
REST OF GCC COUNTRIES: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
REST OF GCC COUNTRIES: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
REST OF GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
REST OF MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
REST OF MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY MECHANISM, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
REST OF MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY COVERAGE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
REST OF MIDDLE EAST & AFRICA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
REST OF MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN GASTROINTESTINAL STENTS MARKET
 
 
 
 
 
 
TABLE 415
GASTROINTESTINAL STENTS MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 416
GASTROINTESTINAL STENTS MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 417
GASTROINTESTINAL STENTS MARKET: PRODUCT FOOTPRINT
 
 
 
 
 
 
TABLE 418
GASTROINTESTINAL STENTS MARKET: TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 419
GASTROINTESTINAL STENTS MARKET: DETAILED LIST OF KEY START-UPS/SMES
 
 
 
 
 
 
TABLE 420
GASTROINTESTINAL STENTS MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
 
 
 
 
 
 
TABLE 421
GASTROINTESTINAL STENTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 422
GASTROINTESTINAL STENTS MARKET: DEALS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 423
GASTROINTESTINAL STENTS MARKET: EXPANSIONS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 424
GASTROINTESTINAL STENTS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 425
BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 426
BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 427
COOK MEDICAL: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 428
COOK MEDICAL: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 429
COOK MEDICAL: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 430
OLYMPUS CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 431
OLYMPUS CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 432
OLYMPUS CORPORATION: DEALS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 433
OLYMPUS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 434
M.I. TECH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 435
M.I. TECH: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 436
M.I. TECH: DEALS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 437
MICRO-TECH (NANJING) CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 438
MICRO-TECH (NANJING) CO., LTD.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 439
MICRO-TECH (NANJING) CO., LTD.: DEALS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 440
MICRO-TECH (NANJING) CO., LTD.: EXPANSIONS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 441
MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 442
MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 443
MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022- MAY 2026
 
 
 
 
 
 
TABLE 444
MEDTRONIC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 445
MEDTRONIC : PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 446
ELLA–CS, S.R.O.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 447
ELLA–CS, S.R.O.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 448
ELLA–CS, S.R.O.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 449
ELLA–CS, S.R.O.: OTHER DEVELOPMENTS, JANUARY 2023−MAY 2026
 
 
 
 
 
 
TABLE 450
STERIS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 451
STERIS: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 452
W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 453
W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 454
W. L. GORE & ASSOCIATES, INC.: DEALS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 455
BD: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 456
BD: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 457
Q3 MEDICAL GROUP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 458
Q3 MEDICAL GROUP: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 459
Q3 MEDICAL GROUP: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 460
Q3 MEDICAL GROUP: OTHER DEVELOPMENTS, JANUARY 2023−MAY 2026
 
 
 
 
 
 
TABLE 461
MEDI-GLOBE GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 462
MEDI-GLOBE GMBH: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 463
HOBBS MEDICAL INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 464
HOBBS MEDICAL INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 465
BVM: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 466
BVM: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 467
STUDY ASSUMPTIONS
 
 
 
 
 
 
TABLE 468
RISK ASSESSMENT ANALYSIS
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
GASTROINTESTINAL STENTS MARKET SEGMENTATION & REGIONAL SCOPE
 
 
 
 
 
 
FIGURE 2
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 3
GLOBAL GASTROINTESTINAL STENTS MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN GASTROINTESTINAL STENTS MARKET, 2023–2025
 
 
 
 
 
 
FIGURE 5
DISRUPTIONS INFLUENCING GROWTH OF GASTROINTESTINAL STENTS MARKET
 
 
 
 
 
 
FIGURE 6
HIGH-GROWTH SEGMENTS IN GASTROINTESTINAL STENTS MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN GASTROINTESTINAL STENTS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 8
STRONG FUTURE FOR MINIMALLY INVASIVE AND ADVANCED GASTROINTESTINAL INTERVENTIONS TO BOOST MARKET GROWTH
 
 
 
 
 
 
FIGURE 9
METAL STENTS AND CHINA DOMINATED MARKET IN 2025
 
 
 
 
 
 
FIGURE 10
APAC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 11
CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 12
DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 13
GASTROINTESTINAL STENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 14
GASTROINTESTINAL STENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 15
GASTROINTESTINAL STENTS MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 16
GASTROINTESTINAL STENTS MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 17
AVERAGE SELLING PRICE OF PLASTIC BILIARY STENTS, BY KEY PLAYER, 2025
 
 
 
 
 
 
FIGURE 18
AVERAGE SELLING PRICE OF GASTROINTESTINAL STENTS, BY REGION, 2025
 
 
 
 
 
 
FIGURE 19
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
FIGURE 20
GASTROINTESTINAL STENTS MARKET: INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
FIGURE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROINTESTINAL STENTS
 
 
 
 
 
 
FIGURE 22
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
 
 
FIGURE 23
GASTROINTESTINAL STENTS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2015–MAY 2026)
 
 
 
 
 
 
FIGURE 24
TOP APPLICANT COUNTRIES/REGIONS FOR GASTROINTESTINAL STENT PATENTS (JANUARY 2015–MAY 2026)
 
 
 
 
 
 
FIGURE 25
AI USE CASES
 
 
 
 
 
 
FIGURE 26
GASTROINTESTINAL STENTS MARKET: GEOGRAPHIC SNAPSHOT
 
 
 
 
 
 
FIGURE 27
NORTH AMERICA: GASTROINTESTINAL STENTS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 28
ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 29
REVENUE ANALYSIS OF KEY PLAYERS IN GASTROINTESTINAL STENTS MARKET (2023−2025)
 
 
 
 
 
 
FIGURE 30
MARKET SHARE ANALYSIS OF KEY PLAYERS IN GASTROINTESTINAL STENTS MARKET, 2025
 
 
 
 
 
 
FIGURE 31
US GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
FIGURE 32
EUROPE GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
FIGURE 33
GASTROINTESTINAL STENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 34
GASTROINTESTINAL STENTS MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 35
GASTROINTESTINAL STENTS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2025
 
 
 
 
 
 
FIGURE 36
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 37
5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 38
BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
 
 
FIGURE 39
BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 40
OLYMPUS CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 41
M.I. TECH: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 42
MICRO-TECH (NANJING) CO., LTD.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 43
MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 44
MEDTRONIC: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 45
STERIS: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 46
BD: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 47
GASTROINTESTINAL STENTS MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 48
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
 
 
 
 
 
 
FIGURE 49
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 50
BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 51
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
 
 
 
 
 
 
FIGURE 52
MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
 
 
 
 
 
 
FIGURE 53
REVENUE SHARE ANALYSIS ILLUSTRATION: BOSTON SCIENTIFIC CORPORATION (2025)
 
 
 
 
 
 
FIGURE 54
TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 55
BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 56
DEMAND-SIDE APPROACH
 
 
 
 
 
 
FIGURE 57
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GASTROINTESTINAL STENTS MARKET (2026–2031)
 
 
 
 
 
 
FIGURE 58
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
 
 
FIGURE 59
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

Methodology

This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

Secondary Research

This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the gastrointestinal stent market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

Primary Research

In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the gastrointestinal stent market. Primary sources from the demand side include gastroenterologists, interventional endoscopists, and surgeons from hospitals and ambulatory surgical centers, as well as directors of endoscopy units and gastrointestinal clinics.

A breakdown of the primary respondents is provided below:

Gastrointestinal Stent Market Size, and Share

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 2: Other designations include sales, marketing, and product managers.

Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the gastrointestinal stent market was determined through data triangulation using three approaches, as outlined below. After each approach, the weighted average of the three approaches was calculated based on the level of assumptions used in each.

Gastrointestinal Stent Market : Top-Down and Bottom-Up Approach

Gastrointestinal Stent Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed where applicable to complete the overall market engineering process and derive the exact statistics for all segments and subsegments.

Market Definition

The gastrointestinal stent market comprises medical devices designed for the minimally invasive management of obstructions, strictures, leaks, and fistulas within the gastrointestinal tract, including the esophagus, stomach, intestines, and biliary system. These stents, primarily self-expanding metal, plastic, and biodegradable variants, are deployed endoscopically or fluoroscopically to restore luminal patency, enable fluid drainage, and support tissue healing in both malignant and benign conditions. The market includes products, delivery systems, and associated technologies used across hospitals, ambulatory surgical centers, and specialty clinics, with applications spanning oncology, post-surgical complications, and chronic gastrointestinal disorders, driven by the growing preference for minimally invasive treatment approaches and improved patient outcomes.

Key Stakeholders

  • GI stent manufacturers (metal, plastic, biodegradable stents)
  • Endoscopy device & delivery system manufacturers
  • Raw material & component suppliers (metals, polymers, coatings)
  • Hospitals & ambulatory surgical centers (public & private)
  • Gastroenterology clinics & endoscopy centers
  • Gastroenterologists, interventional endoscopists & GI surgeons
  • Contract manufacturers & OEM partners
  • Distributors & regional channel partners
  • Academic & clinical research institutions
  • Regulatory authorities & healthcare agencies
  • Market research & consulting firms
  • Investors & private equity firms

Report Objectives

  • To define, describe, segment, and forecast the gastrointestinal stent market by product, type, application, end user, and region
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gastrointestinal stent market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the gastrointestinal stent market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the gastrointestinal stent market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

Customization Options:

With the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe gastrointestinal stent market into Austria, Finland, Switzerland, and other countries
  • Further breakdown of the Rest of Latin America gastrointestinal stent market into Colombia, Chile, and other countries

Competitive Landscape Assessment

  • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the gastrointestinal stent market
  • Competitive leadership mapping for established players in the US

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Gastrointestinal Stent Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Gastrointestinal Stent Market

DMCA.com Protection Status